Unbundling the Secrets of Managing Drug Costs in the Era of Value-Based Care

Hospitals and Health Networks (H&HN): Persistent and pernicious prescription drug cost hyperinflation. A move to bundled payments by both public and private payers. A 3 percent penalty for higher-than-normal readmission rates for several disease states. A sharp focus on outcomes of care in value-based purchasing. The first in a series on leveraging pharmacy services to drive value, this article introduces developing a long-term plan for the pharmacy piece of bundled payments. 

read more

Posted: Tuesday, June 19, 2018

Tags: Industry Published Articles